Introducing The Mane Event, a series where we explore how hair loss (and hair regrowth) has become part of the culture at ...

Prostate cancer stages explain how far cancer has spread. Stage 1 and 2 stay in the prostate and are highly treatable. Stage ...

"She hurled the water in my face before I could even say hello. I burned with humiliation. I knew this wasn’t the end — it ...

A mum was taking lozenges to soothe her painful sore throat, until she was devastated to learn it was cancer - 'most likely ...

Eric Morrow is no stranger to unexpected journeys. News4 caught up with the prostate cancer survivor and Air Force veteran as he headed off on a lifechanging trip. “I wouldn’t wish cancer on anyone, ...

Amidst a heavy work schedule in preparation for the triathlon, we meet ICT Chairperson Dr. Lanka Jayasuriya Dissanayake clad all in pink and Trustee Yenuka Bandularatne, as well as fighter-survivors ...

GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.

A 77-year-old man from Bernalillo County has tested positive for the plague — the second reported case this year — state health officials announced Wednesday. The case comes a month after a ...

Amy Schultze's world was shattered just weeks before graduating when she was diagnosed with a rare and aggressive cancer. Now ...

ASTRO 2025: Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High-Risk Adenocarcinoma of ...

The PCS5 trial is a Canadian multicenter, open-label, phase III randomized trial that included men with histologically proven, clinically localized prostate cancer with ≥1 high-risk feature (s) ...

The agreement includes the transfer of regulatory dossiers, manufacturing competencies and technical support to enable GE HealthCare to drive clinical development in Japan, towards potential ...